Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?

ObjectiveTo evaluate the outcomes after septal myectomy in patients with obstructive hypertrophic cardiomyopathy according to atrial fibrillation and surgical ablation of atrial fibrillation.MethodsWe reviewed patients with obstructive hypertrophic cardiomyopathy who underwent septal myectomy at the Mayo Clinic from 2001 to 2016. History of atrial fibrillation was obtained from patient histories and electrocardiograms. All-cause mortality was the primary end point.ResultsA total of 2023 patients underwent septal myectomy, of whom 394 (19.5%) had at least 1 episode of atrial fibrillation preoperatively. Among patients with atrial fibrillation, 76 (19.3%) had only 1 known episode, 278 (70.6%) had recurrent paroxysmal atrial fibrillation, and 40 (10.2%) had persistent atrial fibrillation. Surgical ablation was performed in 190 patients at the time of septal myectomy, including 148 with pulmonary vein isolation and 42 with the classic maze procedure. Among all patients, operative mortality was 0.4%, and there were no early deaths in patients undergoing surgical ablation. Over a median follow-up of 5.6 years, patients with preoperative atrial fibrillation had increased mortality (hazard ratio, 1.36; 95% confidence interval, 0.97-1.91; P = .070) after multivariable adjustment for comorbidities. When considering the impact of atrial fibrillation with or without surgical treatment, the adjusted hazard ratio for mortality in patients undergoing ablation compared with no ablation was 0.93 (95% confidence interval, 0.52-1.69; P = .824).ConclusionsAtrial fibrillation is present preoperatively in one-fifth of patients with obstructive hypertrophic cardiomyopathy undergoing myectomy and showed a trend toward higher all-cause mortality. Survival of patients undergoing septal myectomy with preoperative atrial fibrillation was similar between those who did and did not receive concomitant surgical ablation.     

Two new secoiridoid glucosides and a new lignan from the roots of <Emphasis Type="Italic">Ilex pubescens</Emphasis>

Two new secoiridoid glucosides, ilexpublignoside (1), pubzenoside (2), and a new lignan, ilexlignan B (3), along with seven known compounds (4–10) were isolated from the roots of Ilex pubescens for the first time. Their chemical structures were elucidated on the basis of extensive spectroscopic methods, including IR, UV, HR-ESI–MS, CD, NMR experiments, as well as comparison with the reported data.     

Effect of Dibutyl Phthalate on the Tolerance and Lipid Accumulation in the Green Microalgae <Emphasis Type="Italic">Chlorella vulgaris</Emphasis>

Offshore oil exploration creates threats to coastal ecosystems, including increasing urbanization and associated effluent releases. Genotoxicity biomarkers in mussels were determined across a gradient of coastal zone influences of offshore petroleum exploration in southeastern Brazil. Coastal ecosystems such as estuaries, beaches and islands were seasonally monitored for genotoxicity evaluation using the brown mussel Perna perna. The greatest DNA damage (5.2%?±?1.9% tail DNA and 1.5‰? ±?0.8‰ MN) were observed in urban estuaries, while Santana Archipelago showed levels of genotoxicity near zero and is considered a reference site. Mussels from urban and pristine beaches showed intermediate damage levels, but were also influenced by urbanization. Thus, mussel genotoxicity biomarkers greatly indicated the proposed oil exploration and urbanization scenarios that consequently are genetically affecting coastal organisms.     

牙龈卟啉单胞菌Hgp44基因的克隆表达与纯化

目的 克隆表达牙龈卟啉单胞菌(Porphyromonas gingivalis,Pg)牙龈素中黏附素区域的Hgp44基因,并纯化目的蛋白.方法 通过聚合酶链反应(PCR)和基因重组技术,克隆得到PgATCC33277的Hgp4基因,插入到克隆载体pMD18-T中并测序鉴定.经过酶切后将目的基因片段与表达载体pET22b相连,构建出表达质粒pET22b-Hgp44.将重组质粒转化到感受态细胞BL21(DE3)中,用异丙基-β-D-硫代半乳糖苷(isopropyl-β-D-thiogalactoside,IPTG)诱导表达融合蛋白,通过SDS聚丙烯酰胺凝胶电泳及蛋白质印迹法进行分析.用固定化金属亲和层析法对重组蛋白进行分离纯化.结果 目的基因片段约为1100 bp,与预期大小相符,测序结果与GenBank中ATCC33277国际标准菌株的RgpA的等位基因序列U15282一致.IPTG诱导后的菌体经SDS聚丙烯酰胺凝胶电泳后形成一个以包涵体形式存在的44 000的融合蛋白.蛋白质印迹法检测证实其具有免疫原性.用镍离子金属螯合层析柱纯化出了目的蛋白,最后得到约3.5 mg/L的目的蛋白.结论 成功克隆表达了PgHgp44基因,并纯化出了目的蛋白.     

新型冠状病毒肺炎防控期间居家隔离人群心理健康状况调查及影响因素分析

目的 了解新型冠状病毒肺炎防控期间居家隔离人群心理健康状况并分析其影响因素,为进一步做好疫情防控工作,疏导不良情绪及心理恐慌提供依据.方法 选取2020年2月15 17日本研究团队7名研究生居住地为调查单位,采用自制一般情况调查表及12项一般健康问卷(GHQ-12)量表调查居家隔离的380人的心理健康状况.根据GHQ-12评分,将调查对象分为GHQ-12≥3分为阳性组(n=212)和GHQ-12＜3分为阴性组(n=168).采用Logistic回归模型分析居家隔离人群心理健康状况的影响因素.结果 两组在年龄、性别、是否独生子女、经济收入方面比较,差异无统计学意义(P＞0.05);而在居住地、婚姻状况、生育情况、担心感染、文化程度、职业方面差异有统计学意义(P＜0.05).多因素Logistic回归分析结果显示,居住地农村、初中及以下文化程度、已婚、学生、外出务工人员、担心感染是居家隔离人群心理健康的危险因素,年龄是其保护因素.结论 新型冠状病毒肺炎防控期间,居家隔离人群存在一定心理健康问题,其受多种因素影响.医院或社区卫生中心应针对不同人群进行心理疏导,改善其身心健康.     

广东粤西地区汉族人群红细胞酸性磷酸酶-腺苷脱氨酶-腺苷酸激酶的遗传学特性

目的:应用红细胞酸性磷酸酶-腺苷脱氨酶-腺苷酸激酶同步电泳分型,从血型遗传学角度对粤西汉族血液中3种酶型的表型分布、基目频率进行调查。方法:实验于2005-03/11在湛江师范学院完成。①血样取自广东湛江地区无血缘关系的汉族健康成人120例,3代内无与外族通婚史。②120例汉族健康成人均取耳血一两滴,渗于无菌纱布上,血痕直径1cm,低温干燥保存,7～14d内进行血痕表型检测。③基因频率计算采用Hardy-Weinbery平衡计算法。种群中某基因频率(%)=种群中该基因总数/种群中该对等位基因总数×100%;种群中某基因型频率(%)=种群中该基因型个体数/该种群的个体数×100%。结果:实验血样取自广东湛江地区无血缘关系的汉族健康成人120例,全部进入结果分析。①粤西汉族酸性磷酸酶、腺苷脱氨酶、腺苷酸激酶3种酶型表现型的观察值与期望值基本吻合(P>0.05),检测的酶型中未发现稀有型、变异型,亦未发现罕见基因。②在粤西汉族群体中,酸性磷酸酶具有中高鉴别能力(积累能力值0.5043),腺苷脱氨酶为低鉴别能力(积累能力值0.2922),而腺苷酸激酶无鉴别能力(积累能力值0.0023)。结论:粤西汉族人群3种检测酶型中未发现稀有型、变异型,亦未发现罕见基因。符合Hardy-Weinbery遗传平衡定律。     

Synergistic Inhibition on Acetylcholinesterase by the Combination of Berberine and Palmatine Originally Isolated from Chinese Medicinal Herbs

Alzheimer’s disease is a multi-factorial neurodegenerative disorder devastatingly affecting the aged population worldwide. Previous studies have shown that medicinal herbs used in traditional Chinese medicine might be benefit to Alzheimer’s disease patients. Berberine and palmatine, two isoquinoline alkaloids found in several medicinal herbs, were used for memory enhancement in China. In this study, the inhibitory effects of combined berberine and palmatine on acetylcholinesteras were evaluated using recombinant human acetylcholinesterase. Our results showed that the combination of berberine and palmatine inhibited acetylcholinesterase in a mixed competitive pattern. By the median-effect principle, the calculated combination index of the combination was less than 1, suggesting that berberine and plamatine inhibited acetylcholinesterase synergistically. Furthermore, the drug-reducing index of berberine and palmatine were 2.98 and 2.66, respectively. Taken together, the results showed that the combination of the two alkaloids might potentially be developed as a more effective therapeutic strategy for Alzheimer’s disease patients.